The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Africa, Europe and North America. The purpose of the trial is to
investigate the efficacy and safety of liraglutide adjunct to insulin treatment in type 1
diabetes.